Register
Forgot your password?

A modern treatment approach of acute myocardialinfarction in patients presenting with ST-segment elevation

Authors: D.V. Skrypnik, R.Yu. Reztsov, O.V. Makarycheva, E.V. Konovalova, E.Yu. Vasilieva, A.V. Shpektor

Company: A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of the RF


For citation: Skrypnik D.V., Reztsov R.Yu., Makarycheva O.V., Konovalova E.V., Vasilieva E.Yu., Shpektor A.V. A modern treatment approach of acute myocardial infarction in patients presenting with ST-segment elevation. Kreativnaya kardiologiya. 2014; 2: 5-14.

Keywords: acute myocardial infarction, STEMI, percutaneous coronary intervention ( PCI)

Full text:  

 

Abstract

This paper is focused on the modern treatment approach of acute myocardial infarction in patients presenting with ST-segment elevation. Particular attention is given to the management of complication of the myocardial infarction.

References

  1. Zimetbaum P.J., Josephson M.E. Use of the electrocardiogram in acute myocardial infarction. N. Engl. J. Med. 2003; 348: 933–40.

  2. Steg G. et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur. Heart J. 2012; 33: 2569–619.

  3. Zijlstra F., Hoorntje J.C., de Boer M.J., Reiffers S., Miedema K. et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N. Engl. J. Med. 1999; 341: 1413–9.

  4. Keeley C., Boura J.A., Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003; 361: 13–20.

  5. Скрыпник Д.В., Васильева Е.Ю., Шпектор А.В. Особенности диагностики и лечения инфаркта миокарда с поражением правого желудочка. Креативная кардиология. 2012; 1: 14–8.

  6. Васильева Е.Ю., Скрыпник Д.В., Назаров А.В., Резцов Р.Ю., Шпектор А.В. Эффективность реперфузионной терапии в зависимости от сроков ее проведения у больных с острым инфарктом миокарда с подъемом сегмента ST. Креативная кардиология. 2010; 2: 31–5.

  7. Bonnefoy E. et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction:a randomised study. Lancet. 2002; 360 (9336):825–9.

  8. Derex L. et al. Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update. J. Neurol. Neurosurg. Psychiatry. 2008; 79: 1093–9.

  9. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet. 1994; 343 (31): 1–22.

  10. Pinto D.S. et al. Benefit of transferring ST-segmentelevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase. Circulation. 2011; 124 (23): 2512–21.

  11. Kalla K., Christ G., Karnik R., Malzer R., Norman G., Prachar H. et al. Implementation of guidelines improves the standard of care: the Viennese registry on reperfusion strategies in ST-elevation myocardial infarction (Vienna STEMI registry). Circulation. 2006; 113: 2398–405.

  12. Henry T.D., Sharkey S.W., Burke M.N., Chavez I.J., Graham K.J. et al. A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction. Circulation. 2007; 116: 721–8.

  13. Le May M.R., So D.Y., Dionne R. et al. A citywide protocol for primary PCI in ST-segment elevation myocardial infarction. N. Engl. J. Med. 2008; 358: 231–40.

  14. Langer A. et al. Late assessment of thrombolytic efficacy (LATE) study: Prognosis in patients with non-Q wave myocardial infarction. J. Am. Coll. Cardiol. 1996; 27 (6): 1327–32.

  15. Kanamasa K. et al. Percutaneous transluminal coronary angioplasty performed 24-48 hours after the onset of acute myocardial infarction improves chronic-phase left ventricular regional wall motion. Angiology. 2000; 51 (4): 281.

  16. Lamberts M. et al. Ongoing treatment with nonsteroidal anti-inflammatory drugs at time of admission is associated with poorer prognosis in patients with first-time acute myocardial infarction. Int. J. Cardiol. 2013; 168 (2): 832–7.

  17. Wiviott S.D., Braunwald E., McCabe C.H. et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med. 2007; 357: 2001–15.

  18. Wallentin L., Becker R.C., Budaj A., Cannon C.P., Emanuelsson H., Held C. et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med. 2009; 361: 1045–57.

  19. Stone G.W., Witzenbichler B., Guagliumi G. et al. Bivalirudin during primary PCI in acute myocardial infarction. N. Engl. J. Med. 2008; 358: 2218–30.

  20. Dickstein K., Cohen-Solal A., Filippatos G., McMurray J.J., Ponikowski P. et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur. Heart J. 2008; 29: 2388–442.

  21. Dargie H.J. et al. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet. 2001; 357: 1385–90.

  22. Packer M., Coats A.J., Fowler M.B., Katus H.A., Krum H. et al. Effect of carvedilol on survival in severe chronic heart failure. N. Engl. J. Med. 2001; 344: 1651–8.

  23. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet. 1995; 345: 669–85.

  24. Menon V., Fincke R. Cardiogenic shock: a summary of the randomized SHOCK trial. Congest. Heart Fail. 2003; 9 (1):35–9.

  25. Amiodarone Trials Meta-Analysis Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Lancet. 1997; 350 (9089): 1417–24.

  26. Vardas P.E., Auricchio A., Blanc J.J., Daubert J.C., Drexler H., Ector H. et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur. Heart J. 2007; 28: 2256–95.

  27. Lemery R., Smith H.C., Giuliani E.R., Gersh B.J. Prognosis in rupture of the ventricular septum after acute myocardial infarction and role of early surgical intervention. Am. J. Cardiol. 1992; 70: 147–51.

  28. Osherov A.B., Borovik-Raz M., Aronson D., Agmon Y. et al. Incidence of early left ventricular thrombus after acute anterior wall myocardial infarction in the primary coronary intervention era. Am. Heart J. 2009; 157: 1074–80.

  29. Solheim S., Seljeflot I., Lunde K., Bjornerheim R. et al. Frequency of left ventricular thrombus in patients with anterior wall acute myocardial infarction treated with percutaneous coronary intervention and dual antiplatelet therapy. Am. J. Cardiol. 2010; 106: 1197–200.

  30. Васильева Е.Ю., Скрыпник Д.В., Назаров А.В., Резцов Р.Ю., Шпектор А.В. Влияние чрескож- ного коронарного вмешательства на госпитальную летальность и клиническое течение острого инфаркта миокарда с подъемом сегмента ST с вовлечением и без вовлечения правого желудочка. Креативная кардиология. 2010; 2: 25–31.

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery


Sort by